Price T Rowe Associates Inc Ionis Pharmaceuticals Inc Transaction History

Price T Rowe Associates Inc

  • $812 Billion
  • Q1 2025

A detailed history of Price T Rowe Associates Inc transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Price T Rowe Associates Inc holds 3,265,034 shares of IONS stock, worth $140 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
3,265,034
Previous 3,826,939 14.68%
Holding current value
$140 Million
Previous $134 Million 26.37%
% of portfolio
0.01%
Previous 0.02%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 14, 2025
SELL
$30.17 - $34.97 $17 Million - $19.6 Million
-561,905 Reduced 14.68%
3,265,034 $98.5 Million
Q4 2024

Feb 14, 2025
SELL
$33.73 - $40.36 $12.9 Million - $15.5 Million
-383,233 Reduced 9.1%
3,826,939 $134 Million
Q3 2024

Nov 14, 2024
BUY
$40.06 - $51.86 $11.1 Million - $14.3 Million
275,861 Added 7.01%
4,210,172 $169 Million
Q2 2024

Aug 14, 2024
BUY
$36.45 - $47.7 $15 Million - $19.7 Million
412,108 Added 11.7%
3,934,311 $188 Million
Q1 2024

May 15, 2024
SELL
$42.03 - $53.55 $30.8 Million - $39.2 Million
-732,871 Reduced 17.22%
3,522,203 $153 Million
Q4 2023

Feb 14, 2024
BUY
$43.39 - $51.63 $21.6 Million - $25.7 Million
497,077 Added 13.23%
4,255,074 $215 Million
Q3 2023

Nov 14, 2023
SELL
$38.5 - $47.13 $3 Million - $3.67 Million
-77,870 Reduced 2.03%
3,757,997 $170 Million
Q2 2023

Aug 14, 2023
SELL
$34.73 - $43.33 $3.44 Million - $4.29 Million
-99,084 Reduced 2.52%
3,835,867 $157 Million
Q1 2023

May 15, 2023
SELL
$33.58 - $41.2 $12 Million - $14.7 Million
-357,480 Reduced 8.33%
3,934,951 $141 Million
Q4 2022

Feb 14, 2023
SELL
$37.12 - $46.52 $18.7 Million - $23.5 Million
-504,701 Reduced 10.52%
4,292,431 $162 Million
Q3 2022

Nov 14, 2022
SELL
$36.54 - $48.66 $375 Million - $499 Million
-10,258,914 Reduced 68.14%
4,797,132 $212 Million
Q2 2022

Aug 15, 2022
BUY
$31.71 - $43.0 $22.4 Million - $30.3 Million
705,586 Added 4.92%
15,056,046 $557 Million
Q1 2022

May 16, 2022
BUY
$29.88 - $37.04 $55.6 Million - $68.9 Million
1,860,180 Added 14.89%
14,350,460 $532 Million
Q4 2021

Feb 14, 2022
BUY
$25.61 - $35.1 $19.3 Million - $26.4 Million
752,959 Added 6.42%
12,490,280 $380 Million
Q3 2021

Nov 15, 2021
SELL
$33.54 - $40.55 $17.5 Million - $21.1 Million
-521,506 Reduced 4.25%
11,737,321 $394 Million
Q2 2021

Aug 16, 2021
SELL
$34.54 - $47.25 $11.1 Million - $15.2 Million
-321,229 Reduced 2.55%
12,258,827 $489 Million
Q1 2021

May 17, 2021
SELL
$42.51 - $63.78 $22.7 Million - $34.1 Million
-534,911 Reduced 4.08%
12,580,056 $566 Million
Q4 2020

Feb 16, 2021
BUY
$45.3 - $60.27 $594 Million - $790 Million
13,114,967 New
13,114,967 $742 Million

Others Institutions Holding IONS

# of Institutions
400
Shares Held
145M
Call Options Held
916K
Put Options Held
552K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $6.08B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email